Clinical Trial Update: EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for EINSTEIN Junior assessing oral rivaroxaban in children with venous thromboembolism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2020-04-01